Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 3796 AL 3810

Two-pore channels (TPCs): Novel voltage-gated ion channels with pleiotropic functions

Feijóo-Bandín S, García-Vence M, García-Rúa V, Roselló-Lletí E, Portolés M, Rivera M, González-Juanatey JR, Lago F.

Channels (Austin). 2017 Jan 2;11(1):20-33. doi: 10.1080/19336950.2016.1213929. Epub 2016 Jul 20.

Mitochondrial lipids in neurodegeneration

Aufschnaiter A, Kohler V, Diessl J, Peselj C, Carmona-Gutierrez D, Keller W, Büttner S.

Cell Tissue Res. 2017 Jan;367(1):125-140. doi: 10.1007/s00441-016-2463-1. Epub 2016 Jul 23.

Role of thrombin in the pathogenesis of central nervous system inflammatory diseases

Ebrahimi S, Jaberi N, Avan A, Ryzhikov M, Keramati MR, Parizadeh MR, Hassanian SM.

J Cell Physiol. 2017 Mar;232(3):482-485. doi: 10.1002/jcp.25501. Epub 2016 Aug 29.

DJ-1 modulates mitochondrial response to oxidative stress: clues from a novel diagnosis of PARK7

Di Nottia M, Masciullo M, Verrigni D, Petrillo S, Modoni A, Rizzo V, Di Giuda D, Rizza T, Niceta M, Torraco A, Bianchi M, Santoro M, Bentivoglio AR, Bertini E, Piemonte F, Carrozzo R, Silvestri G.

Clin Genet. 2017 Jul;92(1):18-25. doi: 10.1111/cge.12841. Epub 2016 Oct 6.

α-Synuclein-carrying extracellular vesicles in Parkinson's disease: deadly transmitters

Chistiakov DA, Chistiakov AA.

Acta Neurol Belg. 2017 Mar;117(1):43-51. doi: 10.1007/s13760-016-0679-1. Epub 2016 Jul 29.

Elevated in vivo [18F]-AV-1451 uptake in a patient with progressive supranuclear palsy

Hammes J, Bischof GN, Giehl K, Faber J, Drzezga A, Klockgether T, van Eimeren T.

Mov Disord. 2017 Jan;32(1):170-171. doi: 10.1002/mds.26727. Epub 2016 Aug 1.

The effect of L-dopa in Parkinson's disease as revealed by neurophysiological studies of motor and sensory functions

Suppa A, Bologna M, Conte A, Berardelli A, Fabbrini G.

Expert Rev Neurother. 2017 Feb;17(2):181-192. doi: 10.1080/14737175.2016.1219251. Epub 2016 Aug 12.

Redox-based therapeutics in neurodegenerative disease

McBean GJ, López MG, Wallner FK.

Br J Pharmacol. 2017 Jun;174(12):1750-1770. doi: 10.1111/bph.13551. Epub 2016 Aug 25.

Coherent and Contradictory Facts, Feats and Fictions Associated with Metal Accumulation in Parkinson's Disease: Epicenter or Outcome, Yet a Demigod Question

Rasheed MSU, Tripathi S, Mishra S, Singh MP.

Mol Neurobiol. 2017 Aug;54(6):4738-4755. doi: 10.1007/s12035-016-0016-y. Epub 2016 Aug 1.

Pharmacokinetics and metabolism of [(14)C]-tozadenant (SYN-115), a novel A2a receptor antagonist ligand, in healthy volunteers

Mancel V, Mathy FX, Boulanger P, English S, Croft M, Kenney C, Knott T, Stockis A, Bani M.

Xenobiotica. 2017 Aug;47(8):705-718. doi: 10.1080/00498254.2016.1221164. Epub 2016 Sep 2.

Water-based vs. non-water-based physiotherapy for rehabilitation of postural deformities in Parkinson's disease: a randomized controlled pilot study

Volpe D, Giantin MG, Manuela P, Filippetto C, Pelosin E, Abbruzzese G, Antonini A.

Clin Rehabil. 2017 Aug;31(8):1107-1115. doi: 10.1177/0269215516664122. Epub 2016 Aug 10.

Brain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence

Kish SJ, Boileau I, Callaghan RC, Tong J.

Eur J Neurosci. 2017 Jan;45(1):58-66. doi: 10.1111/ejn.13363. Epub 2016 Sep 5.

Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease

Lohr KM, Masoud ST, Salahpour A, Miller GW.

Eur J Neurosci. 2017 Jan;45(1):20-33. doi: 10.1111/ejn.13357. Epub 2016 Sep 2.

Delirium prior to dementia as a clinical phenotype of Lewy body disease: an autopsied case report

Fujishiro H, Kawakami I, Oshima K, Niizato K, Iritani S.

Int Psychogeriatr. 2017 Apr;29(4):687-689. doi: 10.1017/S1041610216001265. Epub 2016 Aug 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias